Search Results - "Müller, Timo D"
-
1
GIPR/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applications
Published in Cell metabolism (05-09-2023)“…The incretin system is an essential metabolic axis that regulates postprandial metabolism. The two incretin peptides that enable this effect are the…”
Get full text
Journal Article -
2
Unimolecular Polypharmacy for Treatment of Diabetes and Obesity
Published in Cell metabolism (12-07-2016)“…Many complex diseases have historically proven to be defiant to the best mono-therapeutic approaches. Several examples of combination therapies have largely…”
Get full text
Journal Article -
3
Glucagon Regulation of Energy Expenditure
Published in International journal of molecular sciences (30-10-2019)“…Glucagon's ability to increase energy expenditure has been known for more than 60 years, yet the mechanisms underlining glucagon's thermogenic effect still…”
Get full text
Journal Article -
4
Plasma proteome profiling discovers novel proteins associated with non‐alcoholic fatty liver disease
Published in Molecular systems biology (01-03-2019)“…Non‐alcoholic fatty liver disease (NAFLD) affects 25% of the population and can progress to cirrhosis with limited treatment options. As the liver secretes…”
Get full text
Journal Article -
5
Reappraisal of GIP Pharmacology for Metabolic Diseases
Published in Trends in molecular medicine (01-05-2016)“…Glucagon-like peptide-1 (GLP-1) analogs are considered the best current medicines for type 2 diabetes (T2D) and obesity due to their actions in lowering blood…”
Get full text
Journal Article -
6
Gene therapy targeting the blood-brain barrier improves neurological symptoms in a model of genetic MCT8 deficiency
Published in Brain (London, England : 1878) (19-12-2022)“…A genetic deficiency of the solute carrier monocarboxylate transporter 8 (MCT8), termed Allan-Herndon-Dudley syndrome, is an important cause of X-linked…”
Get full text
Journal Article -
7
Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes
Published in Frontiers in endocrinology (Lausanne) (01-03-2022)“…The incretin hormone glucagon-like peptide-1 (GLP-1) has received enormous attention during the past three decades as a therapeutic target for the treatment of…”
Get full text
Journal Article -
8
Transfer of Proteins from Cultured Human Adipose to Blood Cells and Induction of Anabolic Phenotype Are Controlled by Serum, Insulin and Sulfonylurea Drugs
Published in International journal of molecular sciences (01-03-2023)“…Glycosylphosphatidylinositol-anchored proteins (GPI-APs) are anchored at the outer leaflet of eukaryotic plasma membranes (PMs) only by carboxy-terminal…”
Get full text
Journal Article -
9
Biological Role of the Intercellular Transfer of Glycosylphosphatidylinositol-Anchored Proteins: Stimulation of Lipid and Glycogen Synthesis
Published in International journal of molecular sciences (04-07-2022)“…Glycosylphosphatidylinositol-anchored proteins (GPI-APs), which are anchored at the outer leaflet of plasma membranes (PM) only by a carboxy-terminal GPI…”
Get full text
Journal Article -
10
Bitter taste cells in the ventricular walls of the murine brain regulate glucose homeostasis
Published in Nature communications (22-03-2023)“…The median eminence (ME) is a circumventricular organ at the base of the brain that controls body homeostasis. Tanycytes are its specialized glial cells that…”
Get full text
Journal Article Web Resource -
11
Adipocyte-derived extracellular vesicles increase insulin secretion through transport of insulinotropic protein cargo
Published in Nature communications (09-02-2023)“…Adipocyte-derived extracellular vesicles (AdEVs) are membranous nanoparticles that convey communication from adipose tissue to other organs. Here, to delineate…”
Get full text
Journal Article -
12
Revisiting the Pharmacological Value of Glucagon: An Editorial for the Special Issue "The Biology and Pharmacology of Glucagon"
Published in International journal of molecular sciences (08-01-2020)“…In 1921, a Canadian research team led by Frederick Banting and John Macleod succeeded in the isolation of insulin from pancreatic homogenate [...]…”
Get full text
Journal Article -
13
NBR1 is a critical step in the repression of thermogenesis of p62-deficient adipocytes through PPARγ
Published in Nature communications (17-05-2021)“…Activation of non-shivering thermogenesis is considered a promising approach to lower body weight in obesity. p62 deficiency in adipocytes reduces systemic…”
Get full text
Journal Article -
14
Spatiotemporal GLP-1 and GIP receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists
Published in Molecular metabolism (Germany) (01-07-2021)“…We assessed the spatiotemporal GLP-1 and GIP receptor signaling, trafficking, and recycling dynamics of GIPR mono-agonists, GLP-1R mono-agonists including…”
Get full text
Journal Article -
15
Adipocyte Glucocorticoid Receptor Deficiency Attenuates Aging- and HFD-Induced Obesity and Impairs the Feeding-Fasting Transition
Published in Diabetes (New York, N.Y.) (01-02-2017)“…Glucocorticoids (GCs) are important regulators of systemic energy metabolism, and aberrant GC action is linked to metabolic dysfunctions. Yet, the extent to…”
Get full text
Journal Article -
16
Targeted pharmacological therapy restores β-cell function for diabetes remission
Published in Nature metabolism (01-02-2020)“…Dedifferentiation of insulin-secreting β cells in the islets of Langerhans has been proposed to be a major mechanism of β-cell dysfunction. Whether…”
Get full text
Journal Article -
17
(Patho)Physiology of Glycosylphosphatidylinositol-Anchored Proteins I: Localization at Plasma Membranes and Extracellular Compartments
Published in Biomolecules (Basel, Switzerland) (18-05-2023)“…Glycosylphosphatidylinositol (GPI)-anchored proteins (APs) are anchored at the outer leaflet of plasma membranes (PMs) of all eukaryotic organisms studied so…”
Get full text
Journal Article -
18
Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice
Published in Molecular metabolism (Germany) (01-05-2017)“…Abstract Objective Obesity is a major health threat that affects men and women equally. Despite this fact, weight-loss potential of pharmacotherapies is…”
Get full text
Journal Article -
19
Superior metabolic improvement of polycystic ovary syndrome traits after GLP1-based multi-agonist therapy
Published in Nature communications (01-10-2024)“…Polycystic ovary syndrome (PCOS) is a heterogeneous condition, defined by oligo-/anovulation, hyper-androgenism and/or polycystic ovaries. Metabolic…”
Get full text
Journal Article -
20
Coordinated targeting of cold and nicotinic receptors synergistically improves obesity and type 2 diabetes
Published in Nature communications (23-10-2018)“…Pharmacological stimulation of brown adipose tissue (BAT) thermogenesis to increase energy expenditure is progressively being pursued as a viable anti-obesity…”
Get full text
Journal Article